Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Armed with results from a phase 2 trial, Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor ...

A ranking of the top songs based on streaming and sales activity from within the country- as tracked by Luminate. The ranking is based on a weighted formula incorporating official-only streams ...

Would you like to live in paradise? The perfect temperature, spectacular beaches and enchanting little villages ... what more could you ask for? Discover the magical beauty of the Azores and Madeira!